Monza, Italy

Marco Forzatti



 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marco Forzatti: Innovator in the Field of Beta-Lactamase Inhibition

Introduction

Marco Forzatti is an accomplished inventor based in Monza, Italy, with a notable portfolio of three patents. His work primarily focuses on advancements in the field of pharmaceuticals, particularly in combating bacterial infections.

Latest Patents

One of Marco Forzatti's latest innovations is a patent for a Crystalline beta-lactamase inhibitor. This crystalline compound, represented by formula (I), is designed to act as a β-lactamase inhibitor and can be administered alongside an antibacterial agent for the prevention or treatment of bacterial infections. Additionally, he holds a patent for a Method of forming methyl penam derivatives, which describes a process for creating a compound of formula (IIIa).

Career Highlights

Throughout his career, Marco has contributed his expertise to several pharmaceutical companies, notably Allecra Therapeutics and ACS Dobfar S.p.a. His work has been pivotal in the development of innovative solutions for antibiotic resistance, which remains a significant global healthcare challenge.

Collaborations

In his professional journey, Marco has collaborated with distinguished colleagues such as Giovanni Fogliato and Stefano Biondi. These collaborations have further enriched the research and development processes involved in his patented inventions.

Conclusion

Marco Forzatti’s contributions to the field of pharmaceutical innovation are underscored by his multiple patents and collaborative efforts. His work exemplifies the importance of innovation in addressing pressing medical challenges, particularly in the fight against antibiotic-resistant bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…